Literature DB >> 34417327

Tuberous Sclerosis Complex (TSC) Inactivation Increases Neuronal Network Activity by Enhancing Ca2+ Influx via L-Type Ca2+ Channels.

Chihiro Hisatsune1, Tadayuki Shimada2, Akitoshi Miyamoto3, Amy Lee4, Kanato Yamagata1,5.   

Abstract

Tuberous sclerosis complex (TSC) is a multisystem developmental disorder characterized by hamartomas in various organs, such as the brain, lungs, and kidneys. Epilepsy, along with autism and intellectual disability, is one of the neurologic impairments associated with TSC that has an intimate relationship with developmental outcomes and quality of life. Sustained activation of the mammalian target of rapamycin (mTOR) via TSC1 or TSC2 mutations is known to be involved in the onset of epilepsy in TSC. However, the mechanism by which mTOR causes seizures remains unknown. In this study, we showed that, human induced pluripotent stem cell-derived TSC2-deficient (TSC2 -/-) neurons exhibited elevated neuronal activity with highly synchronized Ca2+ spikes. Notably, TSC2 -/- neurons presented enhanced Ca2+ influx via L-type Ca2+ channels (LTCCs), which contributed to the abnormal neurite extension and sustained activation of cAMP response element binding protein (CREB), a critical mediator of synaptic plasticity. Expression of Cav1.3, a subtype of LTCCs, was increased in TSC2 -/- neurons, but long-term rapamycin treatment suppressed this increase and reversed the altered neuronal activity and neurite extensions. Thus, we identified Cav1.3 LTCC as a critical downstream component of TSC-mTOR signaling that would trigger enhanced neuronal network activity of TSC2 -/- neurons. We suggest that LTCCs could be potential novel targets for the treatment of epilepsy in TSC.SIGNIFICANCE STATEMENT There is a close relationship between elevated mammalian target of rapamycin (mTOR) activity and epilepsy in tuberous sclerosis complex (TSC). However, the underlying mechanism by which mTOR causes epilepsy remains unknown. In this study, using human TSC2 -/- neurons, we identified elevated Ca2+ influx via L-type Ca2+ channels as a critical downstream component of TSC-mTOR signaling and a potential cause of both elevated neuronal activity and neurite extension in TSC2 -/- neurons. Our findings demonstrate a previously unrecognized connection between sustained mTOR activation and elevated Ca2+ signaling via L-type Ca2+ channels in human TSC neurons, which could cause epilepsy in TSC.
Copyright © 2021 the authors.

Entities:  

Keywords:  LTCC; TSC; calcium; epilepsy; mTOR; rapamycin

Mesh:

Substances:

Year:  2021        PMID: 34417327      PMCID: PMC8482857          DOI: 10.1523/JNEUROSCI.1930-20.2021

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  66 in total

1.  Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway.

Authors:  R E Dolmetsch; U Pajvani; K Fife; J M Spotts; M E Greenberg
Journal:  Science       Date:  2001-10-12       Impact factor: 47.728

2.  Spontaneous calcium transients in developing cortical neurons regulate axon outgrowth.

Authors:  Fangjun Tang; Erik W Dent; Katherine Kalil
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

3.  Managing and understanding epilepsy in tuberous sclerosis complex.

Authors:  Elizabeth A Thiele
Journal:  Epilepsia       Date:  2010-02       Impact factor: 5.864

4.  RNA editing of the IQ domain in Ca(v)1.3 channels modulates their Ca²⁺-dependent inactivation.

Authors:  Hua Huang; Bao Zhen Tan; Yiru Shen; Jin Tao; Fengli Jiang; Ying Ying Sung; Choon Keow Ng; Manfred Raida; Georg Köhr; Miyoko Higuchi; Hadi Fatemi-Shariatpanahi; Bradley Harden; David T Yue; Tuck Wah Soong
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

5.  mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis.

Authors:  Veronica Costa; Stefan Aigner; Mirko Vukcevic; Evelyn Sauter; Katharina Behr; Martin Ebeling; Tom Dunkley; Arno Friedlein; Sannah Zoffmann; Claas A Meyer; Frédéric Knoflach; Sebastian Lugert; Christoph Patsch; Fatiha Fjeldskaar; Laurie Chicha-Gaudimier; Anna Kiialainen; Paolo Piraino; Marc Bedoucha; Martin Graf; Sebastian Jessberger; Anirvan Ghosh; Josef Bischofberger; Ravi Jagasia
Journal:  Cell Rep       Date:  2016-03-24       Impact factor: 9.423

6.  Ca2+-dependent facilitation of Cav1.3 Ca2+ channels by densin and Ca2+/calmodulin-dependent protein kinase II.

Authors:  Meagan A Jenkins; Carl J Christel; Yuxia Jiao; Sunday Abiria; Kristin Y Kim; Yuriy M Usachev; Gerald J Obermair; Roger J Colbran; Amy Lee
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

7.  Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Lin Xu; David H Gutmann; Michael Wong
Journal:  Ann Neurol       Date:  2008-04       Impact factor: 10.422

8.  Tuberous sclerosis complex proteins control axon formation.

Authors:  Yong-Jin Choi; Alessia Di Nardo; Ioannis Kramvis; Lynsey Meikle; David J Kwiatkowski; Mustafa Sahin; Xi He
Journal:  Genes Dev       Date:  2008-09-15       Impact factor: 11.361

9.  Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks.

Authors:  Yichen Shi; Peter Kirwan; Frederick J Livesey
Journal:  Nat Protoc       Date:  2012-09-13       Impact factor: 13.491

10.  Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.

Authors:  Ute I Scholl; Gerald Goh; Gabriel Stölting; Regina Campos de Oliveira; Murim Choi; John D Overton; Annabelle L Fonseca; Reju Korah; Lee F Starker; John W Kunstman; Manju L Prasad; Erum A Hartung; Nelly Mauras; Matthew R Benson; Tammy Brady; Jay R Shapiro; Erin Loring; Carol Nelson-Williams; Steven K Libutti; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Peyman Björklund; Tobias Carling; Christoph Fahlke; Patricia Hidalgo; Richard P Lifton
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330

View more
  2 in total

Review 1.  Modeling tuberous sclerosis complex with human induced pluripotent stem cells.

Authors:  Weibo Niu; Benjamin Siciliano; Zhexing Wen
Journal:  World J Pediatr       Date:  2022-06-27       Impact factor: 9.186

Review 2.  Mechanistic target of rapamycin signaling in human nervous system development and disease.

Authors:  Marie Girodengo; Sila K Ultanir; Joseph M Bateman
Journal:  Front Mol Neurosci       Date:  2022-09-26       Impact factor: 6.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.